A Kaplan-Meier survival analysis revealed that decreased ZDHHC1 expression significantly correlated with shorter OS among patients with the following features: clinical stage I–III, complete response (CR), residual tumor (R0), histological type of endometrioid, Black or African American, white, age ≤60, age >60, weight >80, height ≤160 cm, height >160 cm, BMI >30, with or without diabetes, no hormone therapy, and with or without radiation therapy (Figure 4). This evidence concerns the gene ZDHHC1 and diabetes mellitus.